BVFTD

Clinical trials for BVFTD explained in plain language.

Never miss a new study

Get alerted when new BVFTD trials appear

Sign up with your email to follow new studies for BVFTD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Can a synthetic cannabinoid calm agitation in frontotemporal dementia?

Symptom relief Terminated

This phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…

Matched conditions: BVFTD

Phase: PHASE2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief

Last updated Jul 30, 2026 00:00 UTC

BVFTD

Get alerted when new BVFTD trials appear

Can a synthetic cannabinoid calm agitation in frontotemporal dementia?